References
- Sasaki H, Tei C, Nishid K, Nakamura J. Drug release from an ophthalmic insert of a beta-blocker as an ocular delivery system. J Con Rel 1993;27:127–137.
- Kawakami S, Nishida K, Mukai T, Yamamura K, Nakamura J, Sakaeda T, Nakashima M, Sasaki H. Controlled release and ocular absorption of tilisolol utilizing ophthalmic insert-incorporated lipophilic prodrugs. J Con Rel 2001;76:255–263.
- Saettone MF. Progress and problems in ophthalmic drug delivery. Business Briefing Pharmatech 2002;2:1–6.
- Mehanna MM, Elmaradny HA, Samaha MW. Ciprofloxacin liposomes as vesicular reservoirs for ocular delivery: formulation, optimization, and in vitro characterization. Drug Dev Ind Pharm 2008;24:1–11.
- Saettone MF, Salminen L. Ocular inserts for topical delivery. Adv Drug Deliv Rev 1995;16:95–106.
- Charoo NA, Kohli KA, Ali A, Anwer A. Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: In vitro and in vivo studies. Drug Dev Ind Pharm 2003;29(2):215–221.
- Hornof M, Weyenberg W, Ludwig A, Bernkop-Schnurch A. Mucoadhesive ocular insert based on thiolated poly (acrylic acid): Development and in vivo evaluation in humans. J Con Rel 2003;89:419–428.
- Chien YW. Ocular drug delivery systems. In: Chein YW, ed. Novel drug delivery systems. Vol. 2. New York: Marcel Decker Inc; 1988:269–301.
- Rao V, Shyale S. Preparation and evaluation of ocular inserts containing norfloxacin. Turk J Med Sci 2004;34:239–246.
- Vijaya C, Somanath S, Rajan NSMG, Jayaprakash S, Nagarajan M. Controlled release ocuserts of chloramphenicol-design and evaluation. Eastern Pharm 2001;44(250):105–108.
- Rossel CVP, Carreno JS, Rodriguez-Baeza M, Alderete JB. Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and its solid phase. Quimica Nova 2000;23(6):749–752.
- Govindarajan R, Nagarsenker MS. Influence of preparation methodology on solid-state properties of an acidic drug-cyclodextrin system. J Pharm Pharmacol 2004;56:725–733.
- Zingone G, Rubessa F. Preformulation study of the inclusion complex warfarin-β-cyclodextrin. Int J Pharm 2005;291:3–10.
- Chowdary KPR, Rao KRSS, Lakshmi YR. Enhancement of solubility and dissolution rates of Rofecoxib by complexing with β-cyclodextrin. Int J Pharm Excip 2004;3(2):53–56.
- Ali A, Sharma SN. Fabrication of a through flow apparatus for in vitro determination of drugs from ophthalmic preparations. Indian Drugs 1991;29(4):157–160.
- Fresta M, Fontana G, Bucolo C, Cavallaro G, Giammona G, Puglisi G. Ocular tolerability and in vivo bioavailability of polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir. J Pharm Sci 2001;90(3):288–297.
- Martin A, Bustamante PI, Chun AHC. Physical pharmacy. Vol. 4. New Delhi: B.I. Waverly Private Ltd; 1994:315.
- Vijayraghavan C. Practical hand book of physical pharmaceutics. Vol. 1. Madras: New Century Book House (P) Ltd; 1995:30–34.
- Mortazavi SA, Smart JD. An investigation into the role of water movement and mucus gel dehydration in mucoadhesion. J Con Rel 1993;25:197–203.
- Sultana Y, Aqil M, Ali A. Ocular inserts for controlled delivery of pefloxacin mesylate: Preparation and evaluation. Acta Pharm 2005;55:305–314.
- Loukas YL, Yraka V, Gregoriades G. Novel non-acidic formulations of haloperidol complexed with β- cyclodextrin derivatives. J Pharm Biomed Anal 1997;16:263–268.
- Loftsson T, Fridriksdottir H, Thorisdottir S, Stefansson E. The effect of hydroxypropyl methylcellulose on the release of dexamethasone from aqueous 2-hydroxypropyl-β-cyclodextrin formulations. Int J Pharmacol 1994;104:181–184.
- Wang S, Dexin L, Yoshima I, Xia L, Jinghai Z, Chunfu W. An ocular drug delivery system containing zinc diethyldithiocarbamate and HPβCD inclusion complex-corneal permeability, anti-cataract effects and mechanism studies. J Pharm Pharmacol 2004;56:1251–1257.
- Shinde AJ, Garala KC, More HN. Development and characterization of transdermal therapeutics system of tramadol hydrochloride. Asian J Pharm 2008:265–269.
- Mundada AS, Shrikhande BK. Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular drug insert. Curr Eye Res 2008;33:469–475.